Probiodrug AG | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
314.00
94.00
56.00
97.00
106.00
23
Gross Income
314.00
94.00
56.00
97.00
106.00
23
SG&A Expense
10,084.00
11,423.00
13,381.00
13,763.00
9,859.00
7,704
EBIT
10,308.00
11,327.00
13,437.00
13,860.00
9,965.00
7,727
Non Operating Income/Expense
657.00
60.00
68.00
31.00
8.00
12
Interest Expense
115.00
206.00
-
-
-
-
Pretax Income
9,757.00
11,437.00
13,505.00
13,891.00
9,111.00
7,737
Income Tax
-
-
-
-
1,102.00
-
Consolidated Net Income
9,757.00
11,437.00
13,505.00
13,891.00
8,009.00
7,737
Net Income
9,757.00
11,437.00
13,505.00
13,891.00
8,009.00
7,737
Net Income After Extraordinaries
9,585.00
11,437.00
13,505.00
13,891.00
8,009.00
7,737
Net Income Available to Common
9,920.00
11,437.00
13,505.00
13,891.00
8,009.00
7,737
EPS (Basic)
0.39
2.35
1.97
1.82
0.98
0.94
Basic Shares Outstanding
1,951.20
4,862.20
6,871.60
7,619.40
8,188.40
8,208
EPS (Diluted)
5.09
2.35
1.97
1.82
0.98
0.94
Diluted Shares Outstanding
1,951.20
4,862.20
6,871.60
7,619.40
8,188.40
8,208
EBITDA
9,994.00
11,233.00
13,381.00
13,763.00
9,859.00
7,704
Other Operating Expense
90.00
190.00
-
-
-
-
Non-Operating Interest Income
9.00
36.00
-
-
862.00
2
About Probiodrug
View Profile
